Remedor Biomed Overview
Founded
2009
Status
Private
Latest Deal Type
Accelerator/Inc
Investors
1
Remedor Biomed General Information
Description
Provider of a biomedical technology platform based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN). The company develops a formulation, based on erythropoietin and fibronectin, for therapeutical use in tissue regeneration in the processes of wound healing and bone repair.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Social/Platform Software
Primary Office
- Ha-Avoda Street 12
- Nazareth Iliit
- Israel
Remedor Biomed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Remedor Biomed Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Saher Remedor Ph.D | Founder, Chief Technology Officer & Chief Executive Officer |
1 Former Executive
Remedor Biomed Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Next Generation Technology | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial